JANECKOVA, L, Vendula POSPÍCHALOVÁ, Bohumil FAFÍLEK, M VOJTECHOVA, J TURECKOVA, J DOBES, M DUBUISSEZ, D LEPRINCE, N BALOGHOVA, M HORAZNA, A HLAVATA, J STANCIKOVA, E SLONCOVA, K GALUSKOVA, H STRNAD a V KORINEK. HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-kappa B Signaling and Promotes Tissue Damage-Associated Tumorigenesis. MOLECULAR CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH, roč. 13, č. 7, s. 1139-1148. ISSN 1541-7786. doi:10.1158/1541-7786.MCR-15-0033. 2015.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-kappa B Signaling and Promotes Tissue Damage-Associated Tumorigenesis
Autoři JANECKOVA, L, Vendula POSPÍCHALOVÁ, Bohumil FAFÍLEK, M VOJTECHOVA, J TURECKOVA, J DOBES, M DUBUISSEZ, D LEPRINCE, N BALOGHOVA, M HORAZNA, A HLAVATA, J STANCIKOVA, E SLONCOVA, K GALUSKOVA, H STRNAD a V KORINEK.
Vydání MOLECULAR CANCER RESEARCH, PHILADELPHIA, AMER ASSOC CANCER RESEARCH, 2015, 1541-7786.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.510
Doi http://dx.doi.org/10.1158/1541-7786.MCR-15-0033
UT WoS 000358059500008
Změnil Změnila: RNDr. Vendula Hlaváčková Pospíchalová, Ph.D., učo 106199. Změněno: 3. 11. 2015 22:50.
Anotace
Hypermethylated in cancer 1 (HIC1) represents a prototypic tumor suppressor gene frequently inactivated by DNA methylation in many types of solid tumors. The gene encodes a sequence-specific transcriptional repressor controlling expression of several genes involved in cell cycle or stress control. In this study, a Hic1 allele was conditionally deleted, using a Cre/loxP system, to identify genes influenced by the loss of Hic1. One of the transcripts upregulated upon Hic1 ablation is the toll-like receptor 2 (TLR2). Tlr2 expression levels increased in Hic1-deficient mouse embryonic fibroblasts (MEF) and cultured intestinal organoids or in human cells upon HIC1 knockdown. In addition, HIC1 associated with the TLR2 gene regulatory elements, as detected by chromatin immunoprecipitation, indicating that Tlr2 indeed represents a direct Hic1 target. The Tlr2 receptor senses "danger" signals of microbial or endogenous origin to trigger multiple signaling pathways, including NF-kappa B signaling. Interestingly, Hic1 deficiency promoted NF-kB pathway activity not only in cells stimulated with Tlr2 ligand, but also in cells treated with NF-kappa B activators that stimulate different surface receptors. In the intestine, Hic1 is mainly expressed in differentiated epithelial cells and its ablation leads to increased Tlr2 production. Finally, in a chemical-induced mouse model of carcinogenesis, Hic1 absence resulted in larger Tlr2-positive colonic tumors that showed increased proportion of proliferating cells. (C)2015 AACR.
VytisknoutZobrazeno: 19. 4. 2024 23:40